p38 kinase is a key signaling molecule for H-ras-induced cell motility and invasive phenotype in human breast epithelial cells

Cancer Research

Volumn 63, Issue 17, 2003, Pages 5454-5461

  Kim, Mi Sung ^a   Lee, Eun Jung ^a,c   Kim, Hyeong Reh Choi ^b   Moon, Aree ^a  

^a Duksung Women's University   (South Korea)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CJ Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; C JUN AMINO TERMINAL KINASE 1; GELATINASE A; H RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER INVASION; CELL LINE; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN N RAS; SIGNAL TRANSDUCTION; UPREGULATION;

BREAST; BREAST NEOPLASMS; CELL MOVEMENT; ENZYME ACTIVATION; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RAS PROTEINS; UP-REGULATION;

EID: 0141482096     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Fidler, I. J. Critical factors in the biology of human cancer metastasis. Cancer Res., 50: 6130-6138, 1990.
2. Clair, T., Miller, W., and Cho-Chung, Y. Prognostic significance of the expression of the ras protein with a molecular weight of 21, 000 by human breast cancer. Cancer Res., 49: 5290-5293, 1987.
3. Clark, G. J., and Der, C. J. Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res. Treat., 35: 133-144, 1995.
4. Watson, D. M., Elton, R. A., Jack, W. J., Dixon, J. M., Chetty, U., and Miller, W. R. The H-ras oncogene product p21 and prognosis in human breast cancer. Breast Cancer Res. Treat., 17: 161-169, 1991.
5. Barbacid, M. ras genes. Annu. Rev. Biochem., 56: 779-827, 1987.
6. Boguski, M. S., and McCormick, F. Proteins regulating Ras and its relatives. Nature (Lond.), 663: 643-654, 1993.
7. Moon, A., Kim, M. S., Kim, T. G., Kim, S. H., Kim, H. E., Chen, Y. Q., and Kim, H. R. H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: a role for MMP-2 in the H-ras-induced invasive phenotype. Int. J. Cancer, 85: 176-181, 2000.
8. Davis, R. J. Transcriptional regulation by MAP kinases. Mol. Reprod. Dev., 42: 459-467, 1995.
9. Seger, R., and Krebs, E. G. The MAPK signaling cascade. FASEB J., 9: 726-735, 1995.
10. Brunet, A., and Pouyssegur, J. Identification of MAP kinase domains by redirecting stress signals into growth factor responses. Science (Wash. DC), 272: 1652-1655, 1996.
11. Foltz, I. N., Lee, J. C., Young, P. R., and Schrader, J. W. Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway. J. Biol. Chem., 272: 3296-3301, 1997.
12. Ichijo, H., Nishida, E., Irie, K., ten Dijke, P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., and Gotoh, Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science (Wash. DC), 275: 90-94, 1997.
13. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (Wash. DC), 270: 1326-1331, 1995.
14. Rousseau, S., Houle, F., Landry, J., and Han, J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene, 15: 2169-2177, 1997.
15. Matsumoto, T., Yokote, K., Tamura, K., Takemoto, M., Ueno, H., Saito, Y., and Mori, S. Platelet-derived growth factor activates p38 mitogen-activated protein kinase through a Ras-dependent pathway that is important for actin reorganization and cell migration. J. Biol. Chem., 274: 13954-13960, 1999.
16. Hedges, J. C., Dechert, M. A., Yamboliev, I. A., Martin, J. L., Hickey, E., Weber, L. A., and Gerthoffer, W. T. A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. J. Biol. Chem., 274: 24211-24219, 1999.
17. Lakka, S. S., Jasti, S. L., Kyritsis, A. P., Yung, W. K., Ali-Osman, F., Nicolson, G. L., and Rao, J. S. Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades. Clin. Exp. Metastasis, 18: 245-252, 2000.
18. Graf, K., Xi, X. P., Yang, D., Fleck, E., Hsueh, W. A., and Law, R. E. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension, 29: 334-339, 1997.
19. Klemke, R. L., Cai, S., Giannini, A. L., Gallagher, P. J., Lanerolle, P., and Cheresh, D. A. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol., 137: 481-492, 1997.
20. Tryggvason, K. Type IV collagenase in invasive tumors. Breast Cancer Res., 24: 209-218, 1993.
21. Stetler-Stevenson, W. G., Brown, P. D., Onisto, M., Levy, A. T., and Liotta, L. A. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem., 265: 13933-13938, 1990.
22. Bernhard, E. J., Muschel, R. J., and Hughes, E. N. Mr 92, 000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res., 50: 3872-3877, 1990.
23. Bernhard, E. J., Gruber, S. B., and Muschel, R. J. Direct evidence linking expression of matrix metalloproteinase 9 (92 kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA, 91: 4293-4297, 1994.
24. Simon, C., Juarez, J., Nicolson, G. L., and Boyd, D. Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion. Cancer Res., 56: 5369-5374, 1996.
25. Gum, R., Wang, H., Lengyel, E., Juarez, J., and Boyd, D. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene, 14: 1481-1493, 1997.
26. Simon, C., Goepfert, H., and Boyd, D. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92, 000 type IV collagenase secretion and in vitro invasion. Cancer Res., 58: 1135-1139, 1998.
27. Simon, C., Simon, M., Vucelic, G., Hicks, M. J., Plinkert, P. K., Koitschev, A., and Zenner, H. P. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp. Cell Res., 271: 344-355, 2001.
28. Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., and Davis, R. J. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem., 270: 7420-7426, 1995.
29. Sugimoto, T., Stewart, S., Han, M., and Guan, K. L. The kinase supressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAPkinase activation. EMBO J., 17: 1717-1727, 1998.
30. Gupta, S., Campbell, D. D., Derijard, B., and Davis, P. J. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science, 267: 389-393, 1995.
31. Jozaki, K., Marucha, P. T., Despins, A. W., and Kreutzer, D. L. An in vitro model of cell migration: evaluation of vascular endothelial cell migration. Anal. Biochem., 190: 39-47, 1990.
32. Ura, H., Bonfil, R. D., Reich, R., Reddel, R., Pfeifer, A., Harris, C. C., and Klein-Szanto, A. J. P. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res., 49: 4615-4621, 1989.
33. Franks, L. M., and Teich, N. M. Cellular and Molecular Biology of Cancer. Oxford University Press, 1997.
34. Janulis, M., Silberman, S., Ambegaokar, A., Gutkind, S., and Schultz, R. M. Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts. J. Biol. Chem., 274: 801-813, 1999.
35. Raingeaud, J., Whitmarsh, A. J., Barrett, T., Derijard, B., and Davis, R. J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol., 16: 1247-1255, 1996.
36. Bagrodia, S., Derijard, B., Davis, R. J., and Cerione, R. A. Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J. Biol. Chem., 270: 27995-27998, 1995.
37. Derijard, B., Raingeaud, J., Barrett, T., Wu, I. H., Han, J., Ulevitch, R. J., and Davis, R. J. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science (Wash. DC), 267: 682-685, 1995.
38. Zhang, S., Han, J., Sells, M. A., Chernoff, J., Knaus, U. G., Ulevitch, R. J., and Bokoch, G. M. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J. Biol. Chem., 270: 23934-23936, 1995.
39. Chen, G., Masahiro, H., Jiahuai, H., and Dennis, W. S. The p38 pathway provides negative feedback for Ras proliferative signaling. J. Biol. Chem., 275: 38973-38980, 2000.
40. Denkert, C., Siegert, A., Leclere, A., Turzynski, A., and Hauptmann, S. An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells. Clin. Exp. Metastasis, 19: 79-85, 2002.
41. Smolian, H., Aurer, A., Sittinger, M., Zacher, J., Bernimolin, J. P., Burmester, G. R., and Kolkenbrock, H. Secretion of gelatinases and activation of gelatinase A (MMP-2) by human rheumatoid synovial fibroblasts. Biol. Chem., 382: 1491-1499, 2001.
42. Esparza, J., Vilardell, C., Calvo, J., Juan, M., Vives, J., Urbano-Marquez, A., Yague, J., and Cid, M. C. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood, 94: 2754-2766, 1999.
43. Qin, H., Sun, Y., and Benveniste, E. N. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J. Biol. Chem., 274: 29130-29137, 1999.
44. Ellerbrock, S. M., Halbleib, J. M., Benavidez, M., Warmka, J. K., Wattenberg, E. V., Stack, S., and Hudson, L. G. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. Cancer Res., 61: 1855-1861, 2001.